EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Clinical Outcome of Inflammatory Bowel Disease with Clostridioides difficile Polymerase Chain Reaction Toxin-Positive/Enzyme Immunoassay Toxin-Negative: A Retrospective Cohort Study

Junseok Park, Seulji Kim, Jong Pil Im, Hyun Jung Lee, Joo Sung Kim, Hyunsun Park, Yoo Min Han, Seong-Joon Koh

Digestive Diseases and Sciences · 2025

DOI: 10.1007/s10620-025-09045-4 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Digestive Diseases and Sciences, 2025. Verfasst von Junseok Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Clostridium Infections, Clostridioides difficile, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Seoul National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Clostridioides difficile infection (CDI) frequently occurs concurrently in patients with inflammatory bowel disease (IBD), and differential diagnosis from IBD flares is critical. However, clinical management of C. difficile in IBD patients with polymerase chain reaction toxin-positive (tPCR+)/enzyme immunoassay toxin-negative (tEIA-) results has not yet been investigated. AIMS: We aimed to assess the clinical significance of C. difficile tPCR+/tEIA- in patients with IBD and the impact of antibiotic treatment on IBD outcomes. METHODS: This single-center, retrospective cohort study included patients with IBD with CDI test results between January 01, 2018, and August 01, 2022. First, the clinical outcomes of IBD, such as medication escalation, hospitalization, and surgery, were compared between patients with IBD with tPCR-/tEIA- and those with tPCR+/tEIA- using Cox regression and propensity score matching. Next, the clinical outcomes of IBD were assessed based on whether antibiotic treatment for CDI was administered to both groups. RESULTS: Among 412 patients with IBD with PCR test, 71 (17.2%) showed tPCR+/tEIA- results. The tPCR+/tEIA- group showed no statistically significant difference in IBD outcomes compared to the tPCR-/tEIA- group. The antibiotic-treated tPCR+/tEIA- group showed a higher risk of drug escalation and admission than the tPCR-/tEIA- group, while the antibiotic-untreated tPCR+/tEIA- group did not. After drug escalation during the follow-up, the treated tPCR+/tEIA- group showed IBD outcomes similar to those of the tPCR-/tEIA- group. CONCLUSIONS: In patients with IBD with indeterminate CDI, the need for antibiotics should be thoroughly assessed and proper management of underlying IBD such as drug escalation may lead to favorable outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesClostridium InfectionsClostridioides difficileAnti-Bacterial AgentsBacterial ToxinsHumansRetrospective StudiesFemaleMaleMiddle AgedAdultPolymerase Chain ReactionImmunoenzyme TechniquesTreatment OutcomeAged

Stichwörter der Autor:innen

Clostridioides difficileAntibioticsCrohn’s diseaseInflammatory bowel diseaseUlcerative colitis

Substanzen

Anti-Bacterial AgentsBacterial Toxins

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Korea Institute of Radiological and Medical Sciences, Korea Cancer Center Hospital, Seoul, Korea.
  • Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine and Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
  • Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea. jel1206@snu.ac.kr.

Förderung

  • National Research Foundation of Korea
  • Seoul National University

Zitieren

APA

Park, J., Kim, S., Im, J. P., Lee, H. J., Kim, J. S., Park, H., Han, Y. M., & Koh, S. J. (2025). Clinical Outcome of Inflammatory Bowel Disease with Clostridioides difficile Polymerase Chain Reaction Toxin-Positive/Enzyme Immunoassay Toxin-Negative: A Retrospective Cohort Study. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-025-09045-4

Vancouver

Park J, Kim S, Im JP, Lee HJ, Kim JS, Park H, et al. Clinical Outcome of Inflammatory Bowel Disease with Clostridioides difficile Polymerase Chain Reaction Toxin-Positive/Enzyme Immunoassay Toxin-Negative: A Retrospective Cohort Study. Digestive Diseases and Sciences. 2025. doi:10.1007/s10620-025-09045-4

BibTeX
@article{Park2025,
  author = {Park, Junseok and Kim, Seulji and Im, Jong Pil and Lee, Hyun Jung and Kim, Joo Sung and Park, Hyunsun and Han, Yoo Min and Koh, Seong-Joon},
  title = {Clinical Outcome of Inflammatory Bowel Disease with Clostridioides difficile Polymerase Chain Reaction Toxin-Positive/Enzyme Immunoassay Toxin-Negative: A Retrospective Cohort Study},
  journal = {Digestive Diseases and Sciences},
  year = {2025},
  doi = {10.1007/s10620-025-09045-4}
}
Kostenlos starten →